Curative Biotechnology, Inc. (CUBT)
OTCMKTS
· Delayed Price · Currency is USD
0.938
-0.012 (-1.32%)
At close: Apr 28, 2026
Curative Biotechnology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
6.70M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCurative Biotechnology News
- 5 weeks ago - Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting - GlobeNewsWire
- 3 months ago - Curative Biotechnology Announces Canadian Patent Allowance - GlobeNewsWire
- 5 months ago - Curative Biotechnology, Inc. Announces Letter to Shareholders - GlobeNewsWire
- 1 year ago - Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor - GlobeNewsWire
- 2 years ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors - GlobeNewsWire
- 2 years ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors - GlobeNewsWire
- 3 years ago - Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions - GlobeNewsWire
- 3 years ago - Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation - GlobeNewsWire